32. Gartner EM, Silverman P, Simon M, Flaherty L, Abrams J, Ivy P, Lorusso PM: A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer. Breast Cancer Res Treat 2012, 131:933–937.PubMedCrossRef
33. Pacey S, Gore M, Chao D, Banerji U, Larkin J, Sarker S, Owen K, Asad Y, Raynaud F, Walton M, Judson I, Workman P, Eisen T: A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin Selleck SB203580 (17-AAG, tanespimycin) in patients with metastatic melanoma. Invest New Drugs 2012, 30:341–349.PubMedCrossRef 34. Baeuerle PA, Baltimore D: I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 1988, 242:540–546.PubMedCrossRef 35. Hayden MS, West AP, Ghosh S: NF-kappaB and the immune response. Oncogene 2006, 25:6758–6780.PubMedCrossRef 36. Burkly L, Hession C, Ogata L, Reilly C, Marconi LA, Olson D, Tizard R, Cate R, Lo D: Expression of
relB is required for the development of thymic medulla and dendritic cells. Nature 1995, 373:531–536.PubMedCrossRef 37. Fujita S, Seino K, Sato K, Sato Y, Eizumi K, Yamashita N, Taniguchi M, Sato K: Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response. Blood 2006, 107:3656–3664.PubMedCrossRef 38. Bae J, Mitsiades C, Tai YT, Bertheau R, Shammas M, Batchu RB, Li C, Catley L, Prabhala R, Anderson KC, Munshi NC: Phenotypic and functional effects of heat shock protein 90 SN-38 ic50 inhibition on dendritic cell. J Immunol 2007, 178:7730–7737.PubMed 39. Hopkins RA, Connolly JE: The specialized roles of immature and mature dendritic cells in antigen cross-presentation. Immunol Res 2012, 53:91–107.PubMedCrossRef 40. Imai T, Kato Y, Kajiwara C, Mizukami S, Ishige I, Ichiyanagi T, Hikida M, Wang JY, Udono H: Heat shock protein 90 (HSP90) Cetuximab contributes to cytosolic translocation of extracellular antigen for cross-presentation by dendritic cells. Proc Natl Acad Sci USA 2011, 108:16363–16368.PubMedCrossRef 41. Ross R, Jonuleit H, Bros M, Ross XL, Yamashiro S, Matsumura F, Enk AH, Knop J, Reske-Kunz AB: Expression of the actin-bundling
protein fascin in cultured human dendritic cells correlates with dendritic morphology and cell differentiation. J Invest Dermatol 2000, 115:658–663.PubMedCrossRef 42. Taiyab A, Rao CHM: HSP90 modulates actin dynamics: inhibition of HSP90 leads to decreased cell motility and impairs invasion. Biochim Biophys Acta 1813, 2011:213–221. 43. Shurin MR, Lu L, Kalinski P, Stewart-Akers AM, Lotze MT: Th1/Th2 balance in cancer, transplantation and pregnancy. Springer Semin Immunopathol 1999, 21:339–359.PubMedCrossRef 44. Howard M, Roux J, Lee H, Miyazawa B, Lee JW, Gartland B, Howard AJ, Matthay MA, Carles M, Pittet JF: Activation of the stress protein response inhibits the STAT1 click here signalling pathway and iNOS function in alveolar macrophages: role of Hsp90 and Hsp70. Thorax 2010, 65:346–353.PubMedCentralPubMedCrossRef 45.